News
HSIC
75.15
+3.11%
2.27
Have Henry Schein Insiders Been Selling Stock?
Henry Schein, Inc. Insider sold US$478k worth of stock at US$74.28 per share. In the last year, Henry Schein insiders haven't bought any shares. The CEO of North America Distribution Group owns 1.4% of the company. The company doesn't show any insider buying in the last 12 months. Henry Sche in is not the best stock to buy.
Simply Wall St · 1d ago
Weekly Report: what happened at HSIC last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at HSIC last week (0311-0315)?
Weekly Report · 03/18 09:15
Weekly Report: what happened at HSIC last week (0304-0308)?
Weekly Report · 03/11 09:15
Henry Schein Is Maintained at Overweight by JP Morgan
Dow Jones · 03/06 16:05
Henry Schein Price Target Raised to $88.00/Share From $82.00 by JP Morgan
Dow Jones · 03/06 16:05
JP Morgan Maintains Overweight on Henry Schein, Raises Price Target to $88
Benzinga · 03/06 15:55
Henry Schein Is Maintained at Hold by Jefferies
Dow Jones · 03/06 10:34
Henry Schein Price Target Raised to $81.00/Share From $74.00 by Jefferies
Dow Jones · 03/06 10:34
Jefferies Maintains Hold on Henry Schein, Raises Price Target to $81
Benzinga · 03/06 10:24
Henry Schein: Statement of changes in beneficial ownership of securities
Press release · 03/05 23:21
U.S. RESEARCH ROUNDUP-Bark, Fleetcor Technologies, Tesla
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Bark, Fleetcor Technologies and Tesla are among the companies. The analysts raised their ratings on Bark and raised their targets for Fleetcor and Tesla. The companies are all listed on the New York Stock Exchange.
Reuters · 03/05 06:57
Weekly Report: what happened at HSIC last week (0226-0301)?
Weekly Report · 03/04 09:15
Ethisphere Names Henry Schein as One of the 2024 World's Most Ethical Companies® for 13th Consecutive Year
Henry Schein, Inc. Has received the 2024 World’s Most Ethical Companies recognition by Ethisphere. Henry Schein has been recognized since 2012 and is one of only two honorees in the Healthcare Products industry. In 2024, 136 companies were recognized spanning 20 countries and 44 industries.
Barchart · 03/04 05:30
(HSIC) - Analyzing Henry Schein's Short Interest
Henry Schein's short percent of float has risen 4.03% since its last report. The company has 5.23 million shares sold short, which is 4.65% of all regular shares available for trading. Short interest is the number of shares that have been sold short but are not yet covered. Short selling is when a trader sells shares with the hope that the price will fall.
Benzinga · 03/01 19:30
Tracking Al Gore's Generation Investment Management Portfolio - Q4 2023 Update
Al Gore's 13F portfolio value increased from $19B to $22.06B this quarter, with 45 positions in total. The top five stakes in the portfolio are Amazon, Microsoft, Applied Materials, Equifax, and Thermo Fisher Scientific. New stakes include Accenture and Veralto Corp, while the stake in SPDR S&P 500 ETF was dropped.
Seeking Alpha · 02/29 03:00
5 Analysts Assess Henry Schein: What You Need To Know
Henry Schein (NASDAQ:HSIC) has been analyzed by 5 analysts in the last three months. Henry Schein has an average price target of $83.8. The company is a provider of healthcare products and services. The 12-month price targets, analyzed by analysts, offer insights into the company's financial performance.
Benzinga · 02/28 20:00
Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward
Seeking Alpha · 02/28 19:41
Top Stock Movers Now: UnitedHealth, eBay, Axon, and More
The Bureau of Economic Analysis reported the U.S. Economy grew at a slower rate in the fourth quarter than initially thought. The Dow, S&P 500, and Nasdaq were all lower at midday. The price of Bitcoin jumped above $61,000 for the first time since November 2021.
Investopedia · 02/28 17:50
More
Webull provides a variety of real-time HSIC stock news. You can receive the latest news about Henry Schein through multiple platforms. This information may help you make smarter investment decisions.
About HSIC
Henry Schein, Inc. is a solutions company for health care professionals. The Company's business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work to provide quality care. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. The Company's Health Care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products, diagnostic tests, infection-control products, personal protective equipment products (PPE) and vitamins. Its Technology and Value-added services segment provide software, technology and other value-added services to healthcare practitioners. The Company also operates as a supplier of homecare medical products delivered directly to patients in their homes.